A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor

NCT07275242 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: SHR-A1811 Subcutaneous Injection
DRUG: SHR-A1811 for Injection

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.